Vertex Pharmaceuticals, Inc. (VRTX) Posts Q1 Loss of 65c/Share; Reports Statistically Significant KALYDECO + VX-661 Ph. 2 Data

Go back to Vertex Pharmaceuticals, Inc. (VRTX) Posts Q1 Loss of 65c/Share; Reports Statistically Significant KALYDECO + VX-661 Ph. 2 Data